It was recently demonstrated that Myc-induced ADHFE1 forming r-2HG is the main cause of the resulting metabolic reprogramming involving reductive carboxylation glutaminolysis and enhancing mesenchymal transition upon changed epigenetics of breast cancer cells. This evidence concerns the gene MYC and breast cancer.